Synovial hemangioma in the stifle joint of a dog.

Vet Pathol

Animal Disease Diagnostic Laboratory, Department of Veterinary Pathology, Purdue University, 406 S. University St., West Lafayette, IN 47907, USA.

Published: March 2007

Synovial hemangioma was diagnosed in an 8-year-old castrated male Belgian Sheepdog with lameness of 3 months' duration. Pain, soft-tissue swelling, and hemarthrosis were localized to the left stifle joint. Projections of synovial membrane with reddish-purple nodules, excised via arthrotomy, were composed histologically of variably sized vascular channels that were lined by well-differentiated endothelial cells and separated by fibrous septa. Distension of some channels resulted in endothelial disruption, thrombosis, hemorrhage, necrosis, and focal spindle-cell proliferation. The limb was amputated to remove remaining neoplastic tissue. The hemangioma extended focally into the joint capsule and popliteal soft tissue but did not invade skeletal muscle or bone. The dog was free of detectable neoplasia 6 months after amputation. Synovial hemangioma is a rare benign vascular proliferation in people, most commonly in the knee, and should be included in the differential diagnosis for canine synovial tumors.

Download full-text PDF

Source
http://dx.doi.org/10.1354/vp.44-2-240DOI Listing

Publication Analysis

Top Keywords

synovial hemangioma
12
stifle joint
8
synovial
5
hemangioma stifle
4
joint dog
4
dog synovial
4
hemangioma diagnosed
4
diagnosed 8-year-old
4
8-year-old castrated
4
castrated male
4

Similar Publications

The present study was a retrospective single-center study. A total of 81 patients diagnosed with metastatic soft tissue sarcoma were included who received pazopanib therapy. Clinical data, including age at diagnosis, histological subtype, treatments received before pazopanib, number of metastatic sites at the time of initiation of treatment, progression-free survival and overall survival time under pazopanib treatment, side effects and response evaluation in follow-up imaging after initiation of pazopanib therapy, were recorded.

View Article and Find Full Text PDF

Knee Synovial Haemangioma: A Case Report and Imaging Perspective on Diagnosis.

J Belg Soc Radiol

November 2024

Service of Anatomic Pathology, Unidade Local de Saúde São José (ULS São José), Lisbon, Portugal.

Synovial haemangioma is a rare benign entity, most common in children and adolescents. These tumours can extensively infiltrate joint structures and periarticular soft tissues, making management challenging. Magnetic resonance imaging (MRI) has a key role in diagnosis and therapeutic planning.

View Article and Find Full Text PDF

Purpose: Survival of patients with metastatic sarcoma remains poor, and there is a pressing need for new therapies. Most sarcoma subtypes are not responsive to immune checkpoint inhibition alone. Lenvatinib, a multireceptor tyrosine kinase inhibitor targeting tumor vasculature, has an immunomodulatory activity that contributes to its antitumor effects.

View Article and Find Full Text PDF
Article Synopsis
  • Synovial hemangioma is a rare, benign vascular malformation in the knee that can be easily misdiagnosed due to vague symptoms.
  • A 7-year-old boy experienced chronic knee pain and swelling for over 3 years before imaging revealed the condition, leading to successful surgical treatment.
  • Early diagnosis and en-bloc excision of synovial hemangioma are crucial to avoid recurrence and ensure positive outcomes in patients.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!